Overview

Effects of Proxelan Somministration in Patients With Chronic Prostatitis

Status:
Unknown status
Trial end date:
2018-09-30
Target enrollment:
0
Participant gender:
Male
Summary
The purpose of the study is to determinate the antinflammatory effects of the Proxelan on a cohort of patients affected by prostatitis'like symptoms and clinical evidence of abacterical prostatistis, trough a significative improvements of pain symptoms according to the NIH-CPSI questionnaire items, spermatozoa motility/concentration variations and the semen cytokines level decrease.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Pisa
Criteria
Inclusion Criteria:

- prostatitis like symptoms for at least three months

Exclusion Criteria:

- significant post-voidal residual volume

- Meares and Stamey test suggestive for bacterial infection

- neoplasms,

- urinary stones,

- antibiotic therapy in the previous three months,

- irritable bowel syndrome,

- previous radiotherapic or chemiotherapic treatment,

- urethral stenosis,

- neurogenic bladder

- previous prostatic surgery